|
Note to
Psychiatrists:
Schizophrenia patients
(ongoing antipsychotic
treatment inadequate due to
insufficient efficacy and/or
tolerability)
A global
medical research study is
being conducted to document
the clinical benefit of
Quetiapine Sustained Release
(SR) taken once daily
after switching from other
ongoing antipsychotic
treatment, regardless of the
reason for the switch.
Benefit
to your patient:
- A 12 week
treatment period of
treatment with a
flexible dose of
Quetiapine SR.
- As part of the
study, Seroquel® IR is
available
for 6 months
after the treatment
period for patients
doing well.
Please contact one of
the following investigators
for more information:
- Prof. FY Jeenah
(Chris Hani Baragwanath
Hospital, Soweto) +27 11
933 9239
- Dr. MYH Moosa (Chris
Hani Baragwanath
Hospital, Soweto) +27 11
488 3846
- Dr. V Agambaram
(Entabeni Hospital,
Durban) +27 31 261 9120
- Dr. FA Randeree
(Musgrave Park, Durban)
+27 31 201 1531
- Dr. M Slabber (Dey
Clinic, Pretoria) +27 12
460 3502
|
